$HOWL +24% 🚀 Werewolf Therapeutics waking up with biotech momentum 🔹 Q1 net loss narrowed to $13.5M vs. $18.1M last year 📈 🔹 R&D spend dropped sharply as th

$HOWL +24% 🚀 Werewolf Therapeutics waking up with biotech momentum 🔹 Q1 net loss narrowed to $13.5M vs. $18.1M last year 📈 🔹 R&D spend dropped sharply as the company continues tightening operations 🔥 🔹 Strategic alternatives remain the big watch — possible sale, merger, asset sale or licensing…